NOI_SoleSource Blood Analyzers.pdf

PDF 11 KB Posted

Attached to
Notice of Intent to Sole Source - Blood Analyzers
Solicitation number
Not on record
Issued by

About this file

This Notice of Intent (NOI) indicates the Defense Health Agency (DHA) plans to award a sole source contract to Abbott Laboratories Inc. for blood analyzers and related services at Naval Medical Center Portsmouth, VA. The contract will cover twenty-one point-of-care whole blood gas/pH/electrolyte analyzers, along with required reagents, quality control, maintenance, and consumables, with a performance period from September 2025 through August 2026 and four additional option years.

The sole source justification is based on Abbott Laboratories' exclusive rights to produce, distribute, and maintain the iSTAT system, with no other vendors able to provide equivalent handheld analyzers capable of performing specific testing like kaolin activated clotting time and cardiac troponin I testing. Interested sources may submit a 5-page capability statement by 4:30 PM EST on April 15, 2025, to Joshua.m.grim.civ@health.mil, with the subject line "Blood Analyzers". The procurement will be classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and has no set-aside restrictions.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

NOI

The Defense Health Agency (DHA) intends to award a sole source contract under the authority of 13.501(a) Sole

Source (including brand name) acquisitions, to Abbott Laboratories Inc., 200 ABBOTT PARK RD ABBOTT Park

Il 60064 for the provision of all services, materials, and equipment necessary to provide required reagents, quality control, maintenance, consumables, and twenty one (21) analyzers, point-of-care, whole blood, gas/pH/electrolyte

[ECRI device code 18-511] at Naval Medical Center Portsmouth, VA (NMCP). The period of performance of the contract is 01 September 2025 through 31 August 2026 plus 4 option years.

Abbott Laboratories Inc (istat) has executive rights to produce, distribute and maintain the reagents and analyzers that is the istat system. No dealers qualify to work on and/or maintain the product with a warranty agreement.

Abbott Laboratories, Inc. is the only vendor that has handheld analyzer systems capable of performing kaolin activated clotting time testing and cardiac troponin I testing. Additionally, no other vendor manufactures analyzers that can serve as an expansion of the existing iSTAT system currently installed at NMCP.

There are not set-aside restrictions for this requirement. The intended procurement will be classified under North

America Industry Classification System (NAICS) 334516, Analytical Laboratory Instrument Manufacturing. This notice of intent is not a request for competitive proposals and no solicitation exists for this requirement.

Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information, or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.

Capability statements are due by 4:30 PM EST, 15 April 2025. Capability statements shall be submitted by e-mail

ONLY as a Microsoft Word or Adobe PDF attachment to the following address: Joshua.m.grim.civ@health.mil.

IN SUBJECT LINE REFERENCE: "Blood Analyzers".

File details come from the government source that posted it. Updated .